Contineum Therapeutics, Inc. Class A Common Stock
CTNM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,792 | -$16,040 | -$15,990 | -$14,565 |
| Dep. & Amort. | $81 | $79 | $78 | $75 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,569 | $2,418 | $2,569 | $0 |
| Change in WC | -$2,292 | -$1,934 | -$1,082 | $2,950 |
| Other Non-Cash | $237 | -$184 | $13 | $1,338 |
| Operating Cash Flow | -$12,197 | -$15,661 | -$14,412 | -$10,202 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$98 | -$44 | -$47 | -$166 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18,641 | -$25,437 | -$33,691 | -$54,353 |
| Inv. Sales/Matur. | $33,680 | $39,365 | $48,653 | $45,131 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $14,941 | $13,884 | $14,915 | -$9,388 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $19,012 | $267 | $0 | $642 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $93 | -$176 | $24 | $0 |
| Financing Cash Flow | $19,105 | $91 | $24 | $642 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $21,849 | -$1,686 | $527 | -$18,948 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,784 | $22,470 | $21,943 | $40,891 |
| End Cash | $42,633 | $20,784 | $22,470 | $21,943 |
| Free Cash Flow | -$12,295 | -$15,705 | -$14,459 | -$10,368 |